Table 1:
Number and details of the included studies
| Ref. | Original studies (N) | Average cheers score of included studies (%) | Quality status of the included studies | The time frame of the included studies | Country/region | Scope of study | Quality score |
|---|---|---|---|---|---|---|---|
| Ma, et al (7) 2016 | 32 | 77.3 | Very good | 2003–2014 | China | Pharmacoeconomic | 8 |
| Zakiyah, et al (8) 2016 | 9 | 73.5 | Very good | 2006–2013 | Low- and Middle-Income Countries | Family Planning Interventions | 8 |
| Banke-Thomas, et al (9) 2017 | 5 | 90.5 | Excellent | 2002–2011 | Nigeria, Indonesia, Kenya and Tanzania, Mozambique and Zambia | emergency obstetric care training | 8 |
| Gillespie, et al (10) 2017 | 5 | 68.3 | Good | 2000–2016 | Great Britain, Spain, Japan and two studies from Australia | intraoperative interventions to prevent surgical-site infection | 7 |
| Hope, et al (11) 2017 | 14 | 86.7 | Excellent | 2005–2014 | All of the world | population-based sodium reduction interventions | 8 |
| Ibrahim, et al (12) 2017 | 5 | 91.7 | Excellent | 2009–2017 | Western countries | Antimicrobial Stewardship Programs | 8 |
| Iribarren, et al (13) 2017 | 30 | 78.6 | Very good | 2005–2016 | 19 countries, most of which were conducted in upper and upper-middle income countries | MHealth | 8 |
| Melendez-Torres, et al (14) 2017 | 19 | 81.6 | Very good | 2005–2016 | a lot of countries | Drugs | 8 |
| Velentzis, et al (15) 2017 | 5 | 58.3 | Good | 2005–2009 | 2 USA, UK, Finland, Sweden | Menopausal hormone therapy | 7 |
| Wong, et al (16) 2017 | 9 | 89.8 | Excellent | 2001–2014 | Hong Kong | vaccination programs | 8 |
| Dritsaki, et al (17) 2018 | 4 | 98.2 | Excellent | 2011–2015 | 2USA, UK, CANADA | managing Dupuytren’s disease | 8 |
| Grochtdreis, et al (18) 2018 | 15 | 78.1 | Very good | 2004–2018 | UK, US, Austria, Australia, Belgium, Canada, Switzerland, Germany, France, Italy, the Netherlands, New Zealand, Portugal, Sweden | castration-resistant prostate cancer | 7 |
| Jiang, et al (19) 2019 | 14 | 79.2 | Very good | 2011–2018 | Australia, UK, Spain, USA, | Digital Health Interventions on the Management of Cardiovascular Diseases | 8 |
| Ling, et al (20) 2019 | 15 | 58.1 | Good | 2007–2017 | Uganda, Kenya, Afghanistan, Ethiopia, Tanzania, Senegal, Congo, Brazil, Ghana, Sub-Saharan, Nigeria | malaria rapid diagnostic tests | 6 |
| Mendivil, et al (21) 2019 | 33 | 76.5 | Very good | 2012–2018 | Most studies were conducted in Europe (36,4%), followed by United States (24,2%) and Asia (24,2%) | Screening strategies for early detection of colorectal cancer | 7 |
| Sultana, et al (22) 2019 | 19 | 61.3 | Good | 1998–2017 | Germany, USA, France, Malaysia, Scotland, Multicountry (mainly North America), Multicountry (17 countries in Europe, Latin America and South Africa), Belgium, Hong Kong, UK, Spain, Malawi, Netherlands | community acquired pneumonia management strategies | 6 |
| Anopa, et al (23) 2020 | 16 | 79.5 | Very good | 1986–2017 | United States, United Kingdom, Canada, Sweden, Australia, USSR, Chile, Finland, Taiwan, Uzbekistan | Primary prevention of tooth decay in preschool childrenaged 2 to 5 years | 8 |
| dela Perrelle, et al (24) 2020 | 8 | 74.3 | Very good | 1999–2017 | 3The Netherlands,4 United States of America, Niger | Quality Improvement Collaboratives in healthcare | 8 |
| Hao, et al (25) 2020 | 21 | 80.6 | Very good | 2011–2018 | India, South Africa, Uganda, Russia, Eastern Europe, Uganda, USA, Tanzania, Hongkong, Malawi, Brail, Mozambique, Ethiopia | Xpert in detecting Mycobacterium tuberculosis | 7 |
| Niyomsri, et al (26) 2020 | 14 | 90.2 | Excellent | 2002–2017 | Sweden, UK, US, The Netherlands, Canada, | Spinal Cord Stimulation | 8 |
| Ten Ham, et al (27) 2020 | 12 | 82.7 | Very good | 2013–2019 | US, France, | Gene Therapies and Their Application | 8 |
| Woods, et al (28) 2020 | 19 | 78.5 | Very good | 1997–2019 | Peru, Australia, Canada, US, UK, Germany, Netherlands, Sweden, Colombia, Slovakia, China | diabetic foot ulcer infections | 8 |
| Qiu, et al (29) 2021 | 13 | 85.7 | Excellent | 2007–2019 | Belgium, USA, UK, Hong Kong, Southeast Asia, Singapore, Germany, Japan, Italy | Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting | 8 |
| Rezapour, et al (30) 2021 | 26 | 76 | Very good | 2020 | A lot of countries (such as؛ China, Israel, us, Uganda …) | programs against COVID-19 | 8 |
| Schwander, et al (31) 2021 | 4 | 81.2 | Very good | 2007–2014 | UK | Health Economic Obesity Models | 8 |
| Stawowczyk, et al (32) 2018 | 15 | 88.1 | Excellent | 2008–2017 | Canada, the UK and Poland were mostly performed | Biological drugs compared to (conventional, surgery, drugs, etc.) in Ulcerative Colitis | 8 |
| sanyal, et al (33) 2019 | 20 | 84.1 | Very good | 2007–2018 | UK, Spain, France, Netherlands, Belgium, Italy, Canada, USA, Brazil | Community-based services by pharmacists | 7 |
| Avanceña, et al (34) 2021 | 54 | 90.8 | Excellent | 2010–2019 | From all continent | Health Interventions | 8 |
| El Alili, et al (35) 2017 | 45 | 43 | low | 2000–2017 | All Countries | Obstetrics and Gynecology | 6 |
| Ding, et al (36) 2020 | 22 | 96.2 | Excellent | 2010–2019 | countries all over the world, with ten from the USA, seven studies from China (one from Hong Kong), two studies from Canada, one each from Australia, France, Switzerland | immune checkpoint inhibitors for treatment of non-small cell lung cancer | 8 |
| Werner, et al (37) 2020 | 39 | 63.2 | Good | 1983–2019 | low and middle-income countries | emergency care interventions | 7 |
| Galekop, et al (38) 2021 | 49 | 76.3 | Very good | 1987–2017 | Sweden, Switzerland, Australia, UK, USA, Canada | Interventions with a personalized nutrition item in adults | 7 |